Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Clay

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Angewandte Chemie (International Ed. in English)|May 21, 2005
Acetylenic allenophanes: an asymmetric synthesis of a Bis(alleno)-bis(butadiynyl)-meta-cyclophaneMatthew D Clay, Alex G Fallis
Anti-Cancer Drugs|May 31, 2018
Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infectionTimothy D Clay, Samantha E Bowyer
British Medical Journal|August 27, 2010
AN INSULIN-RESISTANT DIABETICR D Clay, R D Lawrence
Trends in Biotechnology|February 6, 2009
Catalytic effectiveness, a measure of enzyme proficiency for industrial applicationsRichard J Fox, Michael D Clay
The Journal of the American Academy of Psychiatry and the Law|September 20, 2008
Commentary: Helling v. Carey, Caveat MedicusD Clay Kelly, Gina Manguno-Mire
The New England Journal of Medicine|February 21, 2014
Post-acute care reform--beyond the ACAD Clay Ackerly, David C Grabowski
Journal of Environmental Management|March 19, 2013
Controls upon biomass losses and char production from prescribed burning on UK moorlandFred Worrall, Gareth D Clay, Richard May
BMJ Case Reports|December 24, 2014
A finding with a diagnosis: I just can't put my finger on itGerard Lambe, Patricia Le, Timothy D Clay
Academic Medicine : Journal of the Association of American Medical Colleges|November 21, 2012
Perspective: A framework for career paths in health systems improvementD Clay Ackerly, Ami Parekh, Daniel Stein
Internal Medicine Journal|July 12, 2019
Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolismTimothy D Clay, Philip Craven, Eli Gabbay
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Angewandte Chemie (International Ed. in English)|May 21, 2005
Acetylenic allenophanes: an asymmetric synthesis of a Bis(alleno)-bis(butadiynyl)-meta-cyclophaneMatthew D Clay, Alex G Fallis
Anti-Cancer Drugs|May 31, 2018
Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infectionTimothy D Clay, Samantha E Bowyer
British Medical Journal|August 27, 2010
AN INSULIN-RESISTANT DIABETICR D Clay, R D Lawrence
Trends in Biotechnology|February 6, 2009
Catalytic effectiveness, a measure of enzyme proficiency for industrial applicationsRichard J Fox, Michael D Clay
The Journal of the American Academy of Psychiatry and the Law|September 20, 2008
Commentary: Helling v. Carey, Caveat MedicusD Clay Kelly, Gina Manguno-Mire
The New England Journal of Medicine|February 21, 2014
Post-acute care reform--beyond the ACAD Clay Ackerly, David C Grabowski
Journal of Environmental Management|March 19, 2013
Controls upon biomass losses and char production from prescribed burning on UK moorlandFred Worrall, Gareth D Clay, Richard May
BMJ Case Reports|December 24, 2014
A finding with a diagnosis: I just can't put my finger on itGerard Lambe, Patricia Le, Timothy D Clay
Academic Medicine : Journal of the Association of American Medical Colleges|November 21, 2012
Perspective: A framework for career paths in health systems improvementD Clay Ackerly, Ami Parekh, Daniel Stein
Internal Medicine Journal|July 12, 2019
Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolismTimothy D Clay, Philip Craven, Eli Gabbay
Pageof 18